Voices: Emil Ciurczak

Looking Towards the Future

A review of the IFPAC Annual Meeting 2018, highlighting the topics and trends that will be guiding pharma in the near future

By Emil W. Ciurczak, contributing editor
Mar 20, 2018

The plenary session early Monday set the overall tone of the conference: “We’re growing because we address what will be happening in pharma, not merely what was done previously,” said Tim Stevens, associate director, Bristol-Myers Squibb, pointing out that while most professional meetings were shrinking, IFPAC was growing, largely due to the agency presence and access to upper echelons of FDA personnel. The thrust of the meeting was the future of pharma — which will clearly be dominated by continuous manufacturing (CM).

Read More